info iconCurrently, the share price for Balaxi Pharmaceuticals Ltd. is delayed.

close icon
Balaxi Pharmaceuticals Ltd. Logo

Balaxi Pharmaceuticals Ltd.

₹627.30
NSE
--   ( -- %) 1D



  • Prev. Close
    627.30
  • Upper Circuit
    752.75
  • Lower Circuit
    501.85

Returns

Balaxi Pharmaceuticals Ltd.'s Info & Management

Balaxi Pharmaceuticals Commenced the business of International Wholesale Trading of Pharmaceuticals, Builders Hardware and FMCG products.
  • Chief Financial Officer
    Mr. Amol Mantri
  • Senior Vice President - Business Development(Business Development)
    Mr. Pranav Maheshwari
  • Company Secretary,Compliance Officer
    Udayan Shukla
  • Chief Financial Officer
    Amol Mantri
  • Senior Vice President - Business Development(Business Development)
    Pranav Maheshwari
  • Head(Alternate Channels)
    Paridhi Maheshwari

FAQs on Balaxi Pharmaceuticals Ltd.

What is the share price of Balaxi Pharmaceuticals Ltd.?

Balaxi Pharmaceuticals Ltd. share price is ₹618.10 as of February 22, 2024, 10:50 AM. Share/stock prices are volatile and change over the course of a trading day, and may differ basis on exchange (NSE/BSE).

What is the 52-week high and low of Balaxi Pharmaceuticals Ltd.?

The 52-week high and low of Balaxi Pharmaceuticals Ltd. is ₹686.30 and ₹400.00 respectively as of February 22, 2024, 10:50 AM. 52-week high and low represent the maximum and minimum value of the share price respectively, over the last 52 weeks (similar to 1 year).

What is the PB ratio of Balaxi Pharmaceuticals Ltd.?

The trailing twelve month (TTM) PB ratio of Balaxi Pharmaceuticals Ltd. is 3.50 as of February 22, 2024. The PB ratio measures the market capitalization of the company relative to it’s book value (carrying value on the balance sheet) as of last reported period.

What are the Upper Circuit and Lower Circuit of Balaxi Pharmaceuticals Ltd.?

The Upper Circuit of Balaxi Pharmaceuticals Ltd. is ₹753. The Lower Circuit of Balaxi Pharmaceuticals Ltd. is ₹502.

What is the ROE of Balaxi Pharmaceuticals Ltd.?

Balaxi Pharmaceuticals Ltd. reported an ROE of 25.13% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.

What is the shareholding pattern of Balaxi Pharmaceuticals Ltd.?

Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Balaxi Pharmaceuticals Ltd., Promoter held 71.2%, the FII held 18.6%, and the public held 10.2% of the total shares.

How to buy Balaxi Pharmaceuticals Ltd. Share?

You can easily buy shares of Balaxi Pharmaceuticals Ltd. online through Share.Market. If you are an existing user, login to your account, else follow the process to create your own Demat and Trading account in a few easy steps.

What is the fair value of Balaxi Pharmaceuticals Ltd.?

The fair value of Balaxi Pharmaceuticals Ltd. is an estimated price at which buyers and sellers would freely trade their shares. The various ways to determine the fair value of an asset include looking at recent market transactions for similar assets, estimating its expected earnings or the cost of replacing it.
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.Disclaimer